Literature DB >> 23238197

Prevalence of ototoxicity in University of Benin Teaching Hospital, Benin city: a 5-year review.

G Obasikene1, Proc Adobamen, P Okundia, F O Ogusi.   

Abstract

BACKGROUND: Ototoxicity refers to damage of the cochlea and/or vestibular apparatus from exposure to chemical substances, resulting in hearing impairment and or disequilibrium. An earlier study carried out at University of Benin Teaching Hospital (UBTH) in 2000 implicated chloramphenicol as the commonest ototoxic drug, followed by antimalarials (Quinine). AIM: To identify the commonly implicated drugs in patients diagnosed with ototoxicity in Ear, Nose and Throat (ENT) Clinic of UBTH.
MATERIALS AND METHODS: One-hundred and three patients' case notes, diagnosed as having ototoxicity, between June 2005 and July 2010 at the ENT Clinic of UBTH were reviewed. Seventy-nine cases met the criteria for diagnosis of ototoxicity in this study.
RESULTS: Intravenous quinine (19.0%) was the commonest implicated drug, followed by oral chloroquine (6.3%), antihypertensive drugs (nifedipine, moduretics, artenolol [6.3%]), native herbal medicine (13.9%), chloramphenicol (1.3%), and unidentifiable drugs accounted for 53.2%. Most patients had severe to profound hearing loss at 4000 Hz and at 8000 Hz. Tinnitus was found in 84.8% of the patients.
CONCLUSION: Quinine is still the commonest implicated ototoxic drug in this part of the country.

Entities:  

Mesh:

Year:  2012        PMID: 23238197     DOI: 10.4103/1119-3077.104527

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  5 in total

1.  Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.

Authors:  Débora Cristina de Oliveira Bezerra; Renata Oliveira de Barcelos; Ellen Carvalho de Castro; Claudia Cristina Jardim Duarte; Raquel de Vasconcellos Carvalhaes Oliveira; Tania Salgado de Sousa Torraca; Maria Helena de Araújo-Melo; Frederico Pereira Bom Braga; Benivaldo Ramos Ferreira Terceiro; Lúcia Regina do Nascimento Brahim Paes; Armando de Oliveira Schubach; Cláudia Maria Valete-Rosalino
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 2.  Common Aminoglycosides and Platinum-Based Ototoxic Drugs: Cochlear/Vestibular Side Effects and Incidence.

Authors:  Robert M DiSogra
Journal:  Semin Hear       Date:  2019-04-26

Review 3.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 4.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003

5.  Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.

Authors:  Yohanna Kambai Avong; Bolajoko Jatau; Ritmwa Gurumnaan; Nanfwang Danat; James Okuma; Istifanus Usman; Dennis Mordi; Blessing Ukpabi; Gbenga Ayodele Kayode; Saswata Dutt; Osman El-Tayeb; Bamgboye Afolabi; Isah Ambrose; Oche Agbaji; Adeline Osakwe; Ali Ibrahim; Comfort Ogar; Helga Nosiri; Eunice B Avong; Victor Adekanmbi; Olalekan Uthman; Alash'le Abimiku; Yetunde O Oni; Charles Olalekan Mensah; Patrick Dakum; Kamau Edward Mberu; Olumide A T Ogundahunsi
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.